4th Quarter - Report
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
Income
—
Expenses
$487,808
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent litigation reform. Issues related to intellectual property practices in foreign countries and impact on US entities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JOHN MYERS | — |
Medicare/Medicaid MMM
Medicare and Medicaid reform including issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE BLOOMQUIST New | — |
| MARIA FIRVIDA | — |
| THERESA JOLIVETTE | — |
| JOHN MYERS | — |
Trade (domestic/foreign) TRD
Trade issues including TPP, TPA, TTIP, and Regulatory Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA FIRVIDA | — |
| JOHN MYERS | — |
Health Issues HCR
Issues related to 21st Century Cures legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE BLOOMQUIST New | — |
| MARIA FIRVIDA | — |
| THERESA JOLIVETTE | — |
| JOHN MYERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.